Clinical trial
Comparison of the Efficacy and Safety of Dopamine, Norepinephrine and Epinephrine in the Treatment of Pulmonary Hypertensive Crisis Under Hemodynamic Monitoring
NCT07667829 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and Safety of Dopamine, Norepinephrine and Epinephrine in the Treatment of Pulmonary Hypertensive Crisis Under Hemodynamic Monitoring
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- January 31, 2029
- Enrollment
- 75 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic thromboembolic pulmonary hypertension (cteph), hypertension, pulmonary, pulmonary arterial hypertension (pah)